PDK1 and hepatocellular carcinoma: Dose‐ and time‐escalating SCT‐1015 treatments were conducted in HCC cells, and the protein abundance of HIF1α and pyruvate dehydrogenase kinase 1 was reduced, with a corresponding increase in Thr172 phosphorylation on the AMPKα (Fig. 6A).